X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AVTX

Closed

Avalo Therapeutics Inc

4.84
-0.15 (-3.01%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.99
Day's Range: 4.797 - 5.05
Send
When Written:
 
1.75
Avalo Therapeutics Inc is a biotechnology company focused on developing cancer therapies. The company's lead product candidate, AVA-001, is a novel therapy designed to target cancer cells while sparing healthy cells. AVA-001 is being developed for the treatment of solid tumors, including breast, lung, and ovarian cancer.

Avalo Therapeutics was founded in 2015 and is headquartered in Durham, North Carolina. The company has raised over $20 million in funding to date, including a $20 million series A financing round in 2019.

The company's management team includes experienced biotech executives with backgrounds in drug development, clinical research, and business operations.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X